224 related articles for article (PubMed ID: 29555409)
1. Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.
Al Jofi FE; Ma T; Guo D; Schneider MP; Shu Y; Xu HHK; Schneider A
Cytotherapy; 2018 May; 20(5):650-659. PubMed ID: 29555409
[TBL] [Abstract][Full Text] [Related]
2. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells.
Wang P; Ma T; Guo D; Hu K; Shu Y; Xu HHK; Schneider A
J Tissue Eng Regen Med; 2018 Feb; 12(2):437-446. PubMed ID: 28494141
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances osteogenic differentiation of stem cells from human exfoliated deciduous teeth through AMPK pathway.
Zhao X; Pathak JL; Huang W; Zhu C; Li Y; Guan H; Zeng S; Ge L; Shu Y
J Tissue Eng Regen Med; 2020 Dec; 14(12):1869-1879. PubMed ID: 33049108
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
[TBL] [Abstract][Full Text] [Related]
5. Combined Use of Recombinant Human BMP-7 and Osteogenic Media May Have No Ideal Synergistic Effect on Leporine Bone Regeneration of Human Umbilical Cord Mesenchymal Stem Cells Seeded on Nanohydroxyapatite/Collagen/Poly (l-Lactide).
E LL; Cheng T; Li CJ; Zhang R; Zhang S; Liu HC; Zheng WJ
Stem Cells Dev; 2020 Sep; 29(18):1215-1228. PubMed ID: 32674666
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin.
Patel H; Younis RH; Ord RA; Basile JR; Schneider A
J Oral Pathol Med; 2013 Mar; 42(3):250-6. PubMed ID: 22861817
[TBL] [Abstract][Full Text] [Related]
7. Runt-Related Transcription Factor 2 Induction During Differentiation of Wharton's Jelly Mesenchymal Stem Cells to Osteoblasts Is Regulated by Jumonji AT-Rich Interactive Domain 1B Histone Demethylase.
Bustos F; Sepúlveda H; Prieto CP; Carrasco M; Díaz L; Palma J; Lattus J; Montecino M; Palma V
Stem Cells; 2017 Dec; 35(12):2430-2441. PubMed ID: 28895234
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum.
Baba K; Yamazaki Y; Ikemoto S; Aoyagi K; Takeda A; Uchinuma E
J Craniomaxillofac Surg; 2012 Dec; 40(8):768-72. PubMed ID: 22503080
[TBL] [Abstract][Full Text] [Related]
9. Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes.
Jiating L; Buyun J; Yinchang Z
Biomed Res Int; 2019; 2019():9203934. PubMed ID: 31886264
[TBL] [Abstract][Full Text] [Related]
10. Endocytic mechanisms and osteoinductive profile of hydroxyapatite nanoparticles in human umbilical cord Wharton's jelly-derived mesenchymal stem cells.
Shi X; Zhou K; Huang F; Zhang J; Wang C
Int J Nanomedicine; 2018; 13():1457-1470. PubMed ID: 29559775
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
12. The Effects of TNF-α on Osteogenic Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells.
Marupanthorn K; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P; Manochantr S
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S34-40. PubMed ID: 26387386
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
14. Decreased intracellular pH induced by cariporide differentially contributes to human umbilical cord-derived mesenchymal stem cells differentiation.
Gao W; Zhang H; Chang G; Xie Z; Wang H; Ma L; Han Z; Li Q; Pang T
Cell Physiol Biochem; 2014; 33(1):185-94. PubMed ID: 24481225
[TBL] [Abstract][Full Text] [Related]
15. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.
Chen W; Liu X; Chen Q; Bao C; Zhao L; Zhu Z; Xu HHK
J Tissue Eng Regen Med; 2018 Jan; 12(1):191-203. PubMed ID: 28098961
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
18. Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells.
Yang SJ; Son JK; Hong SJ; Lee NE; Shin DY; Park SH; An SB; Sung YC; Park JB; Yang HM; Kim SJ
Biochem Biophys Res Commun; 2018 Sep; 504(1):302-308. PubMed ID: 30190122
[TBL] [Abstract][Full Text] [Related]
19. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin.
Balogh E; Tolnai E; Nagy B; Nagy B; Balla G; Balla J; Jeney V
Biochim Biophys Acta; 2016 Sep; 1862(9):1640-9. PubMed ID: 27287253
[TBL] [Abstract][Full Text] [Related]
20. Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.
Sedlinsky C; Molinuevo MS; Cortizo AM; Tolosa MJ; Felice JI; Sbaraglini ML; Schurman L; McCarthy AD
Eur J Pharmacol; 2011 Oct; 668(3):477-85. PubMed ID: 21839072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
